NCT04293029View on ClinicalTrials.gov

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

December 27, 2020

Study Completion Date

December 30, 2020

Conditions
Hepatic Impairment
Interventions
DRUG

SHR0302

SHR0302

Trial Locations (1)

Unknown

The First Affiliated Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04293029 - Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment | Biotech Hunter | Biotech Hunter